Almholt Kasper, Green Kirsty Anne, Juncker-Jensen Anna, Nielsen Boye Schnack, Lund Leif Røge, Rømer John
Finsen Laboratory, Rigshospitalet 3735, Copenhagen BioCenter, Ole Maaløes Vej 5, DK-2200 Copenhagen, Denmark.
J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):83-97. doi: 10.1007/s10911-007-9040-x.
Growth and invasion of breast cancer require extracellular proteolysis in order to physically restructure the tissue microenvironment of the mammary gland. This pathological tissue remodeling process depends on a collaboration of epithelial and stromal cells. In fact, the majority of extracellular proteases are provided by stromal cells rather than cancer cells. This distinct expression pattern is seen in human breast cancers and also in transgenic mouse models of breast cancer. The similar expression patterns suggest that transgenic mouse models are ideally suited to study the role of extracellular proteases in cancer progression. Here we give a status report on protease intervention studies in transgenic models. These studies demonstrate that proteases are involved in all stages of breast cancer progression from carcinogenesis to metastasis. Transgenic models are now beginning to provide vital mechanistic insight that will allow us to combat breast cancer invasion and metastasis with new protease-targeted drugs.
乳腺癌的生长和侵袭需要细胞外蛋白水解作用,以便对乳腺组织微环境进行物理重塑。这种病理性组织重塑过程依赖于上皮细胞和基质细胞的协作。事实上,大多数细胞外蛋白酶是由基质细胞而非癌细胞产生的。这种独特的表达模式在人类乳腺癌以及乳腺癌转基因小鼠模型中均可见到。相似的表达模式表明,转基因小鼠模型非常适合用于研究细胞外蛋白酶在癌症进展中的作用。在此,我们给出关于转基因模型中蛋白酶干预研究的现状报告。这些研究表明,蛋白酶参与了乳腺癌从致癌到转移的所有进展阶段。转基因模型如今开始提供至关重要的机制性见解,这将使我们能够使用新型蛋白酶靶向药物对抗乳腺癌的侵袭和转移。